Candriam Equities L Oncology Fund Class R2H Fonds
191,77
EUR
-0,45
EUR
-0,23
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Eli Lilly and Co | US5324571083 | 6,29% |
| AstraZeneca PLC | GB0009895292 | 4,37% |
| Novartis AG Registered Shares | CH0012005267 | 4,37% |
| Roche Holding AG | CH0012032048 | 4,08% |
| Merck & Co Inc | US58933Y1055 | 3,89% |
| Amgen Inc | US0311621009 | 3,52% |
| Intuitive Surgical Inc | US46120E6023 | 3,15% |
| Pfizer Inc | US7170811035 | 3,09% |
| Danaher Corp | US2358511028 | 3,08% |
| BeOne Medicines Ltd ADR | US07725L1026 | 2,93% |
| Sonstige | 61,22% |